Wayne Harris

1.6k total citations
76 papers, 1.2k citations indexed

About

Wayne Harris is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Wayne Harris has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 35 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in Wayne Harris's work include Renal cell carcinoma treatment (33 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Wayne Harris is often cited by papers focused on Renal cell carcinoma treatment (33 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Bladder and Urothelial Cancer Treatments (16 papers). Wayne Harris collaborates with scholars based in United States, Iran and Türkiye. Wayne Harris's co-authors include Viraj A. Master, Ömer Küçük, Bradley Curtis Carthon, Chris Ibegbu, Joseph D. Miller, Mehmet Asım Bilen, Athena P. Kourtis, Yongxian Xu, Haydn Kissick and Edmund K. Waller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wayne Harris

73 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wayne Harris United States 20 604 377 297 261 199 76 1.2k
Roberto Salgado Belgium 13 893 1.5× 215 0.6× 504 1.7× 271 1.0× 356 1.8× 35 1.5k
Peng Chen China 17 467 0.8× 405 1.1× 448 1.5× 137 0.5× 259 1.3× 113 1.2k
Yi Zhao China 19 304 0.5× 159 0.4× 311 1.0× 140 0.5× 190 1.0× 71 1.1k
Man‐Hsin Hung Taiwan 21 488 0.8× 273 0.7× 537 1.8× 214 0.8× 232 1.2× 45 1.4k
Jingjing Zhao China 18 594 1.0× 307 0.8× 378 1.3× 287 1.1× 214 1.1× 72 1.2k
Hiroki Hayashi Japan 21 624 1.0× 291 0.8× 360 1.2× 110 0.4× 107 0.5× 78 1.2k
Jason Clark United States 16 645 1.1× 143 0.4× 311 1.0× 271 1.0× 190 1.0× 29 1.2k
Masahiko Watanabe Japan 22 716 1.2× 382 1.0× 450 1.5× 205 0.8× 177 0.9× 78 1.9k

Countries citing papers authored by Wayne Harris

Since Specialization
Citations

This map shows the geographic impact of Wayne Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wayne Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wayne Harris more than expected).

Fields of papers citing papers by Wayne Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wayne Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wayne Harris. The network helps show where Wayne Harris may publish in the future.

Co-authorship network of co-authors of Wayne Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Wayne Harris. A scholar is included among the top collaborators of Wayne Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wayne Harris. Wayne Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yuan, Dylan J. Martini, Wayne Harris, et al.. (2025). Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.. Journal of Clinical Oncology. 43(5_suppl). 512–512. 1 indexed citations
2.
Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. SHILAP Revista de lepidopterología. 5(3). 52–57. 1 indexed citations
3.
Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in Oncology. 11. 701345–701345. 7 indexed citations
4.
Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in Oncology. 11. 707050–707050. 26 indexed citations
5.
Martini, Dylan J., Yuan Liu, Julie M. Shabto, et al.. (2021). Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer Treatment and Research Communications. 28. 100393–100393. 4 indexed citations
6.
Shabto, Julie M., Dylan J. Martini, Yuan Liu, et al.. (2020). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 9(8). 2752–2760. 8 indexed citations
7.
Harvey, R. Donald, Bradley Curtis Carthon, Colleen Lewis, et al.. (2020). Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British Journal of Cancer. 123(8). 1228–1234. 11 indexed citations
8.
Yousuf, Seema, Fahim Atif, Claudia Espinosa‐García, et al.. (2020). Stroke-Induced Peripheral Immune Dysfunction in Vitamin D–Deficient Conditions: Modulation by Progesterone and Vitamin D. Molecular Neurobiology. 58(3). 950–963. 4 indexed citations
9.
Voss, Martin H., Arif Hussain, Nicholas J. Vogelzang, et al.. (2017). A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma. Annals of Oncology. 28(11). 2754–2760. 66 indexed citations
10.
Patil, Dattatraya, Jeffrey Pearl, Mehmet Asım Bilen, et al.. (2017). A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma. Asian journal of urology. 4(4). 230–238. 13 indexed citations
11.
Huang, Jonathan, Mehrdad Alemozaffar, Kenneth Ogan, et al.. (2015). C-reactive protein in urologic cancers. Molecular Aspects of Medicine. 45. 28–36. 25 indexed citations
12.
Şahin, Kazım, Nurhan Şahin, Shadeah Suleiman, et al.. (2015). Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model. Archives of Biochemistry and Biophysics. 572. 36–39. 19 indexed citations
13.
Harris, Wayne. (2015). Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma. Molecular Aspects of Medicine. 45. 47–54. 5 indexed citations
14.
Tucker‐Burden, Carol, Prasanthi Chappa, Malini Krishnamoorthy, et al.. (2012). Lectins Identify Glycan Biomarkers on Glioblastoma-Derived Cancer Stem Cells. Stem Cells and Development. 21(13). 2374–2386. 30 indexed citations
15.
Yin-Goen, Qiqin, Timothy V. Johnson, Wei Han, et al.. (2010). Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients. Tumor Biology. 32(2). 375–380. 5 indexed citations
16.
Waller, Edmund K., Jonathan R. Murrow, Amita K. Manatunga, et al.. (2009). Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. American Heart Journal. 158(1). 53–60.e1. 51 indexed citations
17.
Parker, Kathy P., Donald L. Bliwise, Maria H.L. Ribeiro, et al.. (2008). Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography. Journal of Clinical Oncology. 26(15). 2464–2472. 86 indexed citations
18.
Lonial, Sagar, Claire Torre, Ebenezer David, et al.. (2008). Regulation of alloimmune responses by dendritic cell subsets. Experimental Hematology. 36(10). 1309–1317. 11 indexed citations
19.
Mabjeesh, Nicola J., Margaret Willard, Wayne Harris, et al.. (2003). Dibenzoylmethane, a natural dietary compound, induces HIF-1α and increases expression of VEGF. Biochemical and Biophysical Research Communications. 303(1). 279–286. 32 indexed citations
20.
Burri, Stuart H., Caryn N. Kim, Guofu Fang, et al.. (1999). ‘loop’ domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis. International Journal of Radiation Oncology*Biology*Physics. 43(2). 423–430. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Salgado Breakdown of academic impact, for papers by Peng Chen Breakdown of academic impact, for papers by Yi Zhao Breakdown of academic impact, for papers by Man‐Hsin Hung Breakdown of academic impact, for papers by Jingjing Zhao Breakdown of academic impact, for papers by Hiroki Hayashi Breakdown of academic impact, for papers by Jason Clark Breakdown of academic impact, for papers by Masahiko Watanabe
Rankless by CCL
2026